Data availability
The data that support the findings of this study are available upon reasonable request from the corresponding author, AGOL.
References
Beiteke U, Bigge S, Reichenberger C, Gralow I (2015) Pain and pain management in dermatology. J Dtsch Dermatol Ges 13(10):967–987. https://doi.org/10.1111/ddg.12822
Erickson KM, Kody S, Ortega-Loayza AG (2023) Pain as a patient reported outcome measure in pyoderma gangrenosum: defining clinical significance. JAMA Dermatol, Accepted for publication
Hobbs MM, Byler R, Latour E, Bonomo L, Hennessy K, Cruz-Diaz C N, Shinohara MM, Seminario-Vidal L, Shinkai K, Ortega-Loayza AG (2021) Treatment of pyoderma gangrenosum: a multicenter survey-based study assessing satisfaction and quality of life. Dermatol Ther 34(2):e14736. https://doi.org/10.1111/dth.14736
Ormerod AD, Thomas KS, Craig FE, Mitchell E, Greenlaw N, Norrie J, Mason JM, Walton S, Johnston G A, Williams HC, UK Dermatology Clinical Trials Network’s STOP GAP Team (2015) Comparison of the two most commonly used treatments for pyoderma gangrenosum: results of the STOP GAP randomised controlled trial. BMJ (Clinical research Ed.), 350: h2958. https://doi.org/10.1136/bmj.h2958
Reese AM, Gupta AS, Latour E, Loyo M, Kaffenberger B, Creadore A, Mostaghimi A, Seminario-Vidal L, Rick J, Ortega-Loayza AG (2022) Clinical characteristics and misdiagnosis of pyoderma gangrenosum of the head and neck: a retrospective study. J Am Acad Dermatol 87(5):1130–1133. https://doi.org/10.1016/j.jaad.2022.02.008
Funding
None.
Author information
Authors and Affiliations
Contributions
LTT participated in writing the original draft, project administration and data curation. SK participated in writing the original draft and review and editing. JARD participated in data curation and completed the formal data analysis. AGOL conceptualized and supervised the project and reviewed and edited the manuscript. All authors reviewed the manuscript.
Corresponding author
Ethics declarations
Conflict of interest
Dr. Ortega-Loayza is President-elect of the Pacific Dermatology Association and serves as an associate editor for Dermatology. Additionally, he is a consultant for Genentech and Guidepoint and an advisor to Bristol Meyer Squibb, Boehringer Ingelheim and Janssen. Dr. Ortega has received research grants from Lilly, Janssen and Pfizer. The other authors have no conflicts of interest to disclose.
IRB approval
This study was approved by Oregon Health & Science University’s Institutional Review Board (IRB #21834).
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Taylor, L.T., Kody, S., Rios-Duarte, J.A. et al. Impact of diagnostic delay on patient perspectives in pyoderma gangrenosum: an online support group-based survey study. Arch Dermatol Res 315, 2737–2739 (2023). https://doi.org/10.1007/s00403-023-02685-4
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00403-023-02685-4